BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lammers GJ, Bassetti CL, Dolenc-groselj L, Jennum PJ, Kallweit U, Khatami R, Lecendreux M, Manconi M, Mayer G, Partinen M, Plazzi G, Reading PJ, Santamaria J, Sonka K, Dauvilliers Y. Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep Medicine Reviews 2020;52:101306. [DOI: 10.1016/j.smrv.2020.101306] [Cited by in Crossref: 27] [Cited by in F6Publishing: 39] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Veauthier C, Kallweit U, Geisler P, Mayer G. Aktuelle Entwicklungen in der Schlafforschung und Schlafmedizin – eine Einschätzung der AG „Narkolepsie, Hypersomnie und Hypersomnolenz“. Somnologie. [DOI: 10.1007/s11818-022-00378-0] [Reference Citation Analysis]
2 Zhao M, Zhang B, Tang J, Zhang X. The Impact of Sleep Pattern in School/Work Performance During the COVID-19 Home Quarantine in Patients With Narcolepsy. Front Neurol 2022;13:849804. [DOI: 10.3389/fneur.2022.849804] [Reference Citation Analysis]
3 Craig S, Pépin JL, Randerath W, Caussé C, Verbraecken J, Asin J, Barbé F, Bonsignore MR. Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view. Eur Respir Rev 2022;31:210230. [PMID: 35613742 DOI: 10.1183/16000617.0230-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bonsignore MR, Lombardi C, Lombardo S, Fanfulla F. Epidemiology, Physiology and Clinical Approach to Sleepiness at the Wheel in OSA Patients: A Narrative Review. JCM 2022;11:3691. [DOI: 10.3390/jcm11133691] [Reference Citation Analysis]
5 Pizza F, Barateau L, Dauvilliers Y, Plazzi G. The orexin story, sleep and sleep disturbances. J Sleep Res 2022;:e13665. [PMID: 35698789 DOI: 10.1111/jsr.13665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Barateau L, Pizza F, Plazzi G, Dauvilliers Y. 50th anniversary of the ESRS in 2022-JSR special issue. J Sleep Res 2022;:e13631. [PMID: 35624073 DOI: 10.1111/jsr.13631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 van der Hoeven AE, Fronczek R, Schinkelshoek MS, Roelandse FWC, Bakker JA, Overeem S, Bijlenga D, Lammers GJ. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1. Sleep 2022;45:zsac052. [PMID: 35554594 DOI: 10.1093/sleep/zsac052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Latorre D, Federica S, Bassetti CLA, Kallweit U. Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation. Semin Immunopathol 2022. [PMID: 35445831 DOI: 10.1007/s00281-022-00933-9] [Reference Citation Analysis]
9 Strauss M, Griffon L, Van Beers P, Elbaz M, Bouziotis J, Sauvet F, Chennaoui M, Léger D, Peigneux P. Order matters: sleep spindles contribute to memory consolidation only when followed by rapid-eye-movement sleep. Sleep 2022;45:zsac022. [PMID: 35037060 DOI: 10.1093/sleep/zsac022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Akyildiz UO, Tezer FI, Koc G, Ismailogullari S, Demir AB, Ak AK, Sunter G, Kara KA, Berktas DT, Sahin A, Azman F, Akcay BD, Gok DK, Yilmaz H, Agan K, Bekmezci Y, Yetkin S, Aksu M, Karadeniz D, Senel GB. The REM-sleep related characteristics of narcolepsy: A nation-wide multi-center study in Turkey, the REMCON study. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.03.025] [Reference Citation Analysis]
11 Leclair-visonneau L. Orientation diagnostique devant une plainte d’hypersomnolence. La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.01.004] [Reference Citation Analysis]
12 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Vitiello MV, Tang X, Sanford LD. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis. Sleep Medicine Reviews 2022. [DOI: 10.1016/j.smrv.2022.101610] [Reference Citation Analysis]
13 Billiard M, Sonka K. Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria. NSS 2022;Volume 14:311-22. [DOI: 10.2147/nss.s266090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol 2022;21:53-65. [PMID: 34942138 DOI: 10.1016/S1474-4422(21)00368-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
15 Xin X, Cheng L, Li S, Feng L, Xin Y, Wang S. Improvement to the subjective well-being of pet ownership may have positive psychological influence during COVID-19 epidemic. Anim Sci J 2021;92:e13624. [PMID: 34459072 DOI: 10.1111/asj.13624] [Reference Citation Analysis]
16 Evangelista E, Rassu AL, Lopez R, Biagioli N, Chenini S, Barateau L, Jaussent I, Dauvilliers Y. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia. Sleep 2021:zsab220. [PMID: 34436617 DOI: 10.1093/sleep/zsab220] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Maski KP, Colclasure A, Little E, Steinhart E, Scammell TE, Navidi W, Diniz Behn C. Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence. Sleep 2021;44:zsab021. [PMID: 33512510 DOI: 10.1093/sleep/zsab021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gauld C, Lopez R, Geoffroy PA, Morin CM, Guichard K, Giroux É, Dauvilliers Y, Dumas G, Philip P, Micoulaud-franchi J. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration. Sleep Medicine Reviews 2021;58:101439. [DOI: 10.1016/j.smrv.2021.101439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Torstensen EW, Pickering L, Kornum BR, Wanscher B, Baandrup L, Jennum PJ. Diagnostic value of actigraphy in hypersomnolence disorders. Sleep Med 2021;85:1-7. [PMID: 34265481 DOI: 10.1016/j.sleep.2021.06.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollmächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res 2021;:e13387. [PMID: 34173288 DOI: 10.1111/jsr.13387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollmächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ. European guideline and expert statements on the management of narcolepsy in adults and children. Eur J Neurol 2021;28:2815-30. [PMID: 34173695 DOI: 10.1111/ene.14888] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
22 Sivam S, Chamula K, Swieca J, Frenkel S, Saini B. Narcolepsy management in Australia: time to wake up. Med J Aust 2021;215:62-63.e1. [PMID: 34145573 DOI: 10.5694/mja2.51150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Plante DT, Papale LA, Madrid A, Cook JD, Prairie ML, Alisch RS. PAX8/PAX8-AS1 DNA methylation levels are associated with objective sleep duration in persons with unexplained hypersomnolence using a deep phenotyping approach. Sleep 2021:zsab108. [PMID: 34145460 DOI: 10.1093/sleep/zsab108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Evangelista E, Rassu AL, Barateau L, Lopez R, Chenini S, Jaussent I, Dauvilliers Y. Characteristics associated with hypersomnia and excessive daytime sleepiness identified by extended polysomnography recording. Sleep 2021;44:zsaa264. [PMID: 33249509 DOI: 10.1093/sleep/zsaa264] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Ollila HM. Narcolepsy type 1: what have we learned from genetics? Sleep 2020;43:zsaa099. [PMID: 32442260 DOI: 10.1093/sleep/zsaa099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Sanford LD, Tang X. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis. Sleep Med Rev 2021;58:101488. [PMID: 33934047 DOI: 10.1016/j.smrv.2021.101488] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Dietmann A, Wenz E, van der Meer J, Ringli M, Warncke JD, Edwards E, Schmidt MH, Bernasconi CA, Nirkko A, Strub M, Miano S, Manconi M, Acker J, von Manitius S, Baumann CR, Valko PO, Yilmaz B, Brunner AD, Tzovara A, Zhang Z, Largiadèr CR, Tafti M, Latorre D, Sallusto F, Khatami R, Bassetti CLA. The Swiss Primary Hypersomnolence and Narcolepsy Cohort study (SPHYNCS): Study protocol for a prospective, multicentre cohort observational study. J Sleep Res 2021;:e13296. [PMID: 33813771 DOI: 10.1111/jsr.13296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Nevsimalova S, Susta M, Prihodova I, Horvat EM, Milata M, Sonka K. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med 2021;80:86-91. [PMID: 33588261 DOI: 10.1016/j.sleep.2021.01.031] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Med 2021;80:315-21. [PMID: 33631500 DOI: 10.1016/j.sleep.2021.01.018] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Dietmann A, Gallino C, Wenz E, Mathis J, Bassetti CLA. Multiple sleep latency test and polysomnography in patients with central disorders of hypersomnolence. Sleep Med 2021;79:6-10. [PMID: 33453460 DOI: 10.1016/j.sleep.2020.12.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Gauld C, Dumas G, Darrason M, Salles N, Desvergnes P, Philip P, Micoulaud-franchi J. Médecine du sommeil personnalisée et syndrome d’apnées hypopnées obstructives du sommeil : entre précision et stratification, une proposition de clarification. Médecine du Sommeil 2020;17:213-30. [DOI: 10.1016/j.msom.2020.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Gool JK, Cross N, Fronczek R, Lammers GJ, van der Werf YD, Dang-vu TT. Neuroimaging in Narcolepsy and Idiopathic Hypersomnia: from Neural Correlates to Clinical Practice. Curr Sleep Medicine Rep 2020;6:251-66. [DOI: 10.1007/s40675-020-00185-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S. Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. J Immunother Cancer 2020;8:e001164. [PMID: 33004543 DOI: 10.1136/jitc-2020-001164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Baumann-Vogel H, Schreckenbauer L, Valko PO, Werth E, Baumann CR. Narcolepsy type 2: A rare, yet existing entity. J Sleep Res 2021;30:e13203. [PMID: 32989797 DOI: 10.1111/jsr.13203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Lammers GJ, Bassetti CL, Dauvilliers Y. Reply to Micoulaud-Franchi et al. Commentary on diagnosis of central disorders of hypersomnolence: From clinic to clinic via ontology and semantic analysis on a bullet point path. Sleep Medicine Reviews 2020;52:101329. [DOI: 10.1016/j.smrv.2020.101329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Maski K, Mignot E, Scammell TE. COMMENTARY on Lammers et al, Diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence. Sleep Medicine Reviews 2020;52:101327. [DOI: 10.1016/j.smrv.2020.101327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Gauld C, Ouazzani K, Micoulaud-franchi J. Commentary on Lammers et al. “Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts”: From clinic to clinic via ontology and semantic analysis on a bullet point path. Sleep Medicine Reviews 2020;52:101328. [DOI: 10.1016/j.smrv.2020.101328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Billiard M. Diagnosing hypersomnolence. Sleep Medicine Reviews 2020;52:101343. [DOI: 10.1016/j.smrv.2020.101343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lammers GJ, Bassetti CL, Dauvilliers Y. Reply to Maski K et al. commentary on diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence. Sleep Medicine Reviews 2020;52:101326. [DOI: 10.1016/j.smrv.2020.101326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]